Evidence map›Paper›PMID 34782333›Full record

ArticleBMJ open diabetes research & care2021

Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms.

Darren M Riddy, Helene L Kammoun, Andrew J Murphy, Sanja Bosnyak-Gladovic, Rocio De la Fuente Gonzalez, Jon Merlin, Mark Ziemann, Stewart Fabb, Tracie L Pierce, Natalie Diepenhorst and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Darren M Riddy *Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia darren.riddy@monash.edu chris.langmead@monash.edu.ORCID 0000-0003-0524-1498
Helene L Kammoun *Haematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Andrew J Murphy *Haematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Sanja Bosnyak-GladovicDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Rocio De la Fuente GonzalezDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Jon MerlinDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.ORCID 0000-0002-0062-795X
Mark ZiemannDepartment of Diabetes, Monash University Central Clinical School, Melbourne, Victoria, Australia.
Stewart FabbDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Tracie L PierceDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Natalie DiepenhorstDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Patricia RuedaDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Assam El-OstaDepartment of Diabetes, Monash University Central Clinical School, Melbourne, Victoria, Australia.
Jean-Francois GautierInserm UMRS 1138, Département Diabète et Endocrinologie, Sorbonne Université, Paris, France.
Nicolas VenteclefInserm UMRS 1138, Département Diabète et Endocrinologie, Sorbonne Université, Paris, France.
William N CharmanDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Arthur ChristopoulosDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Patrick M SextonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Roger J SummersDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Mark A FebbraioDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Philippe DelerivePôle d'Innovation Thérapeutique Métabolisme, Institut de Recherches Internationales Servier, Suresnes, France.
Christopher J LangmeadDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia darren.riddy@monash.edu chris.langmead@monash.edu.
Monash University · AUBaker Heart and Diabetes Institute · AUInserm · FRThe Alfred Hospital · AUServier (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA potential role for the orphan G protein-coupled receptor, GPR21, in linking immune cell infiltration into tissues and obesity-induced insulin resistance has been proposed, although limited studies in mice are complicated by non-selective deletion of RESEARCH DESIGN AND

methodsWe hypothesized that a

resultsHigh-fat feeding studies in

conclusionsCollectively, human and mouse data suggest that GPR21 influences both glucose homeostasis and MCP-1/CCL2-CCR2-driven monocyte migration. However, a

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceAnimalsChemokine CCL2GlucoseHomeostasisHumansLeukocytes, MononuclearMiceReceptors, CCR2Receptors, G-Protein-CoupledCCL2 protein, humanCCR2 protein, humanCcr2 protein, mouseChemokine CCL2GlucoseGPR21 protein, humanGPR21 protein, mouseReceptors, CCR2Receptors, G-Protein-Coupledchemokinesdiabetes mellitusG-protein-coupledinflammationreceptorstype 2

Identifiers

PMID34782333
PMCPMC8593704
OpenAlexW3213423131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.